FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

HTTP error: 503HTTP error: 503HTTP error: 503
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

2.

Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer

3.

FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.

4.

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

5.

Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot